Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne S De Groot

Showing results (41-50 of 177) with videos related to

Pageof 18
Sort By:
Human Vaccines & Immunotherapeutics|April 10, 2012
New vaccines needed for pathogens infecting animals and humans: One HealthAndres H Gutiérrez, Denice M Spero, Cyril Gay, et al.
Rhode Island Medical Journal (2013)|December 2, 2015
Barriers to Health Insurance Pre- and Post-Affordable Care Act Implementation in Providence, RIJennifer Pigoga, Farzana Kibria, Mauricio Pinilla, et al.
Preventing Chronic Disease|November 21, 2024
Continuity of Care and Lifestyle Intervention Programs for Spanish-Speaking Immigrants Without Health Insurance at a Free Clinic in Rhode IslandChilsea Wang, Jocelyn Yang, Julia Testa, et al.
Contemporary Clinical Trials Communications|November 13, 2018
Community clinic-based lifestyle change for prevention of metabolic syndrome: Rationale, design and methods of the 'Vida Sana/healthy life' programPatricia Markham Risica, Meghan McCarthy, Katherine Barry, et al.
BMC Bioinformatics|March 22, 2013
Computational vaccinology and the ICoVax 2012 workshopYongqun He, Zhiwei Cao, Anne S De Groot, et al.
Expert Review of Vaccines|January 8, 2024
Neoadjuvant personalized cancer vaccines: the final frontier?Guilhem Richard, Nicole Ruggiero, Gary D Steinberg, et al.
International Journal for Parasitology|June 5, 2003
T cell epitope identification for bovine vaccines: an epitope mapping method for BoLA A-11Anne S De Groot, Vishvanath Nene, Nagendra R Hegde, et al.
Clinical Immunology (Orlando, Fla.)|January 17, 2017
De-immunized and Functional Therapeutic (DeFT) versions of a long lasting recombinant alpha interferon for antiviral therapyEduardo F Mufarrege, Sofía Giorgetti, Marina Etcheverrigaray, et al.
Rhode Island Medical Journal (2013)|October 31, 2020
Responding to COVID-19 in an Uninsured Hispanic/Latino Community: Testing, Education and Telehealth at a Free Clinic in ProvidenceKatherine Barry, Meghan McCarthy, Gillian Melikian, et al.
Clinical Immunology (Orlando, Fla.)|November 23, 2013
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigationVibha Jawa, Leslie P Cousens, Michel Awwad, et al.
Pageof 18

Showing results (41-50 of 177) with videos related to

Sort By:
Pageof 18
Human Vaccines & Immunotherapeutics|April 10, 2012
New vaccines needed for pathogens infecting animals and humans: One HealthAndres H Gutiérrez, Denice M Spero, Cyril Gay, et al.
Rhode Island Medical Journal (2013)|December 2, 2015
Barriers to Health Insurance Pre- and Post-Affordable Care Act Implementation in Providence, RIJennifer Pigoga, Farzana Kibria, Mauricio Pinilla, et al.
Preventing Chronic Disease|November 21, 2024
Continuity of Care and Lifestyle Intervention Programs for Spanish-Speaking Immigrants Without Health Insurance at a Free Clinic in Rhode IslandChilsea Wang, Jocelyn Yang, Julia Testa, et al.
Contemporary Clinical Trials Communications|November 13, 2018
Community clinic-based lifestyle change for prevention of metabolic syndrome: Rationale, design and methods of the 'Vida Sana/healthy life' programPatricia Markham Risica, Meghan McCarthy, Katherine Barry, et al.
BMC Bioinformatics|March 22, 2013
Computational vaccinology and the ICoVax 2012 workshopYongqun He, Zhiwei Cao, Anne S De Groot, et al.
Expert Review of Vaccines|January 8, 2024
Neoadjuvant personalized cancer vaccines: the final frontier?Guilhem Richard, Nicole Ruggiero, Gary D Steinberg, et al.
International Journal for Parasitology|June 5, 2003
T cell epitope identification for bovine vaccines: an epitope mapping method for BoLA A-11Anne S De Groot, Vishvanath Nene, Nagendra R Hegde, et al.
Clinical Immunology (Orlando, Fla.)|January 17, 2017
De-immunized and Functional Therapeutic (DeFT) versions of a long lasting recombinant alpha interferon for antiviral therapyEduardo F Mufarrege, Sofía Giorgetti, Marina Etcheverrigaray, et al.
Rhode Island Medical Journal (2013)|October 31, 2020
Responding to COVID-19 in an Uninsured Hispanic/Latino Community: Testing, Education and Telehealth at a Free Clinic in ProvidenceKatherine Barry, Meghan McCarthy, Gillian Melikian, et al.
Clinical Immunology (Orlando, Fla.)|November 23, 2013
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigationVibha Jawa, Leslie P Cousens, Michel Awwad, et al.
Pageof 18